Literature DB >> 22776937

Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.

Maurizio Battaglia Parodi, Marialucia Cascavilla, Alexandros Papayannis, Dimitrios Stelios Kontadakis, Francesco Bandello, Pierluigi Iacono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22776937     DOI： 10.1001/archophthalmol.2011.2617

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  3 in total

Review 1.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Sharon D Solomon; Kristina Lindsley; Satyanarayana S Vedula; Magdalena G Krzystolik; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2014-08-29

2.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Sharon D Solomon; Kristina Lindsley; Satyanarayana S Vedula; Magdalena G Krzystolik; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2019-03-04

3.  Management of significant reactivation of old disciform scars in wet age-related macular degeneration.

Authors:  Rosa M Coco; Anna Sala-Puigdollers
Journal:  BMC Ophthalmol       Date:  2014-06-25       Impact factor: 2.209
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.